The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126781851 12678185 1 I 20160816 20160823 20160823 EXP ES-MYLANLABS-2016M1035076 MYLAN PASCUAL O, URIARTE M, AGUSTIN M-J, GIMENO V, LARRODE I, ABAD M-R. TWO CASES OF BREAST CARCINOMA DURING PREGNANCY AND REVIEW OF THE LITERATURE. J-ONCOL-PHARM-PRACT 2016;22(4):652-656. 0.00 Y 0.00000 20160823 OT ES ES

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126781851 12678185 1 PS DOXORUBICIN DOXORUBICIN 1 Intravenous (not otherwise specified) 25 MG/M2 FROM DAYS 1-3 AT EVERY 3 WEEKS Y U 200170 INJECTION
126781851 12678185 2 SS PACLITAXEL. PACLITAXEL 1 Intravenous (not otherwise specified) 80 MG/M2 U U 0 INJECTION
126781851 12678185 3 C ONDANSETRON ONDANSETRON 1 Intravenous (not otherwise specified) U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126781851 12678185 1 Invasive ductal breast carcinoma
126781851 12678185 2 Invasive ductal breast carcinoma
126781851 12678185 3 Antiemetic supportive care

Outcome of event

Event ID CASEID OUTC COD
126781851 12678185 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126781851 12678185 Anaemia
126781851 12678185 Asthenia
126781851 12678185 Dyspepsia
126781851 12678185 Exposure during pregnancy
126781851 12678185 Fatigue
126781851 12678185 Mucosal inflammation
126781851 12678185 Neutropenia
126781851 12678185 Pyrexia
126781851 12678185 Respiratory tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found